CEFTAZIDIME - Generic Drug Details

What are the generic sources for ceftazidime and what is the scope of patent protection?

Ceftazidime is the generic ingredient in ten branded drugs marketed by Acs Dobfar, Aurobindo Pharma Ltd, Wockhardt, B Braun, Glaxosmithkline, Pai Holdings Pharm, Hospira, Lilly, and Baxter Hlthcare, and is included in sixteen NDAs. Additional information is available in the individual branded drug profile pages.

There are seventeen drug master file entries for ceftazidime. Three suppliers are listed for this compound.

Summary for CEFTAZIDIME

US Patents:	0
Tradenames:	10
Applicants:	9
NDAs:	16
Drug Master File Entries:	17
Finished Product Suppliers / Packagers:	3
Raw Ingredient (Bulk) Api Vendors:	42
Clinical Trials:	67
Patent Applications:	7,320
Formulation / Manufacturing:	see details
What excipients (inactive ingredients) are in CEFTAZIDIME?	CEFTAZIDIME excipients list
DailyMed Link:	CEFTAZIDIME at DailyMed

Recent Clinical Trials for CEFTAZIDIME

Identify potential brand extensions & 505(b)(2) entrants

Sponsor	Phase
Qianfoshan Hospital	N/A
Arrevus Inc.	Phase 2
King Faisal Specialist Hospital & Research Center	Phase 3

See all CEFTAZIDIME clinical trials

Pharmacology for CEFTAZIDIME

Drug Class

Cephalosporin Antibacterial

Medical Subject Heading (MeSH) Categories for CEFTAZIDIME

Anti-Bacterial Agents

US Patents and Regulatory Information for CEFTAZIDIME

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
B Braun	CEFTAZIDIME IN DEXTROSE CONTAINER	ceftazidime	INJECTABLE;INJECTION	050823-002	Jun 13, 2011		DISCN	Yes	No
Baxter Hlthcare	CEFTAZIDIME SODIUM IN PLASTIC CONTAINER	ceftazidime sodium	INJECTABLE;INJECTION	063221-003	Apr 29, 1993		DISCN	No	No
Hospira	TAZICEF	ceftazidime	INJECTABLE;INJECTION	062662-004	Mar 6, 1986	AP	RX	No	No